ProPhase Labs (PRPH) Debt to Equity (2016 - 2025)
Historic Debt to Equity for ProPhase Labs (PRPH) over the last 9 years, with Q3 2025 value amounting to $0.39.
- ProPhase Labs' Debt to Equity rose 16697.03% to $0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.39, marking a year-over-year increase of 16697.03%. This contributed to the annual value of $1.34 for FY2024, which is 80410.97% up from last year.
- Per ProPhase Labs' latest filing, its Debt to Equity stood at $0.39 for Q3 2025, which was up 16697.03% from $0.25 recorded in Q2 2025.
- Over the past 5 years, ProPhase Labs' Debt to Equity peaked at $1.34 during Q4 2024, and registered a low of $0.12 during Q2 2022.
- In the last 5 years, ProPhase Labs' Debt to Equity had a median value of $0.18 in 2021 and averaged $0.25.
- Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 8198.59% in 2021, then skyrocketed by 80410.97% in 2024.
- Quarter analysis of 5 years shows ProPhase Labs' Debt to Equity stood at $0.17 in 2021, then crashed by 30.93% to $0.12 in 2022, then increased by 26.1% to $0.15 in 2023, then surged by 804.11% to $1.34 in 2024, then tumbled by 70.82% to $0.39 in 2025.
- Its Debt to Equity was $0.39 in Q3 2025, compared to $0.25 in Q2 2025 and $0.28 in Q1 2025.